Login

E-mail

Password

Register now

Past programme

CME application in progress

GR0 - 08 September 2010 - 09:43-09:43 CET

Topics: -

View details

Improve training opportunities for cancer control professionals: Career progression, Funding and fellowships, Scientific networking in the Facebook era (in co-operation with UICC www.uicc.org) CME accredited

GR86 - 25 February 2010 - 18:15-19:00 CET

Expert: Nicol Keith, UICC, Project Chair for the International Cancer Technology Transfer Fellowships, Geneva, Switzerland
Discussant: Dominik Berthold, University Hospital of Canton Vaud, Lausanne, Switzerland
Topics: General interest  

View details

Minimally invasive surgery for the treatment of prostate cancer: Myth and reality CME accredited

GR85 - 18 February 2010 - 18:15-19:00 CET

Expert: Karim Touijer, Memorial Sloan Kettering Cancer Centre, New York, USA
Discussant: Xavier Cathelineau, Institut Mutualiste Montsouris, Paris, France
Topics: Genito-urinary cancers   Surgical oncology  

View details

Diagnosis and classification of myeloproliferative neoplasms: Importance of histology and genetics (Review Article published in Nature Reviews Clinical Oncology) CME accredited

GR82 - 28 January 2010 - 18:15-19:00 CET

Expert: Ayalew Tefferi, Mayo Clinic, Rochester, MN , USA
Discussant: Luciano Wannesson, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Topics: -

View details

Universal availability of effective pain control (in co-operation with UICC www.uicc.org) CME accredited

GR81 - 21 January 2010 - 18:15-19:00 CET

Expert: Eduardo Bruera, M.D. Anderson Cancer Center, Houston, USA
Discussant: Sebastiano Mercadante, Pain Relief and Palliative Care Unit, La Maddalena, Palermo, Italy
Topics: -

View details

New developments in brachytherapy for prostate cancer CME accredited

GR78 - 10 December 2009 - 18:15-19:00 CET

Expert: Michael Zelefsky, Memorial Sloan Kettering Cancer Centre, New York, USA
Discussant: Alberto Bossi, Institut Gustave Roussy, Villejuif, France
Topics: -

View details

Breast cancer and pregnancy: How safe is trastuzumab? (Case Study published in Nature Clinical Practice Oncology) CME accredited

GR77 - 03 December 2009 - 18:15-19:00 CET

Expert: Hatem Azim, Jules Bordet Institute, Brussels, Belgium
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milano, Italy
Topics: -

View details

Breast cancer heredity (in co-operation with OECI) CME accredited

GR76 - 26 November 2009 - 18:15-19:00 CET

Expert: Stefania Tommasi, Scientific Institute for Research and Treatment of Cancer Giovanni Paolo II, Bari, Italy
Discussant: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
Topics: -

View details

Integration of biology and high-technology in modern radiation oncology CME accredited

GR74 - 12 November 2009 - 18:15-19:00 CET

Expert: Michael Baumann, Carl Gustav Carus University Clinic, Dresden, Germany
Discussant: Daniel Zips, Carl Gustav Carus University Clinic, Dresden, Germany
Topics: -

View details

Cancer on the Internet: Will we be able to adapt quickly enough? CME accredited

GR70 - 15 October 2009 - 18:15-19:00 CET

Expert: Alex Jadad, Centre for Global Health Innovation, Toronto General Hospital, Toronto, Canada
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: -

View details

Innovations in breast cancer radiotherapy CME accredited

GR69 - 08 October 2009 - 18:15-19:00 CET

Expert: Luis Schiappacasse Soffia, Instituto Madrileno de Oncologia, Madrid, Spain
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: -

View details

Micro RNAs in clinical oncology: At the crossroads between promises and problems CME accredited

GR68 - 01 October 2009 - 18:15-19:00 CET

Expert: George M. Yousef, St. Michael s Hospital, University of Toronto, Toronto, Canada
Discussant: Christine Brezden-Masley, St. Michael s Hospital, University of Toronto, Toronto, Canada
Topics: -

View details

Epidemiology of breast cancer: Are biology and outcome different around the world? CME accredited

GR67 - 24 September 2009 - 18:15-19:00 CET

Expert: Peter Boyle, International Prevention Research Institute, Lyon, France
Discussant: Laura Biganzoli, Hospital of Prato, Prato, Italy
Topics: -

View details

New perspectives in colorectal cancer CME accredited

GR66 - 17 September 2009 - 18:15-19:00 CET

Expert: John L. Marshall, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington D.C., USA
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: -

View details

Role of industry-sponsored and independent trials in the development of new anticancer drugs (in co-operation with OECI) CME accredited

GR65 - 10 September 2009 - 18:15-19:00 CET

Expert: Paolo Bruzzi, Institute for Cancer Research, Genoa, Italy
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Discussant: Peter Brauchli, CEO, SAKK - Swiss Group for Clinical Cancer Research, Berne, Switzerland
Topics: -

View details

The evolving role of maintenance therapy for advanced non-small cell lung cancer CME accredited

GR63 - 27 August 2009 - 18:15-19:00 CET

Expert: Howard (Jack) West, Swedish Cancer Institute, Seattle, USA
Discussant: Martin Frueh, Cantonal Hospital, St. Gallen, Switzerland
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: -

View details

Current status of accelerated partial breast irradiation CME accredited

GR62 - 20 August 2009 - 18:15-19:00 CET

Expert: Frank Vicini, William Beaumont Hospital, Royal Oak, USA
Discussant: Douglas W. Arthur, Virginia Commonwealth University Medical Center, Richmond, USA
Topics: -

View details

Overview on anti-HER2 therapy in HER2-positive breast cancer patients CME accredited

GR61 - 13 August 2009 - 18:15-19:00 CET

Expert: Tanja Cufer, University Clinic Golnik, Golnik, Slovenia
Discussant: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
Topics: Breast cancer  

View details

Heterogeneity in cancer guidelines: Should we eradicate or tolerate? (based on an Original Article published in Annals of Oncology) CME accredited

GR60 - 06 August 2009 - 18:15-19:00 CET

Expert: George Pentheroudakis, University of Ioannina, School of Medicine, Ioannina, Greece
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: -

View details

Bisphosphonates: Proposal for marker directed therapy and the truth about antitumour activity CME accredited

GR59 - 30 July 2009 - 18:15-19:00 CET

Expert: Robert Coleman, Weston Park Hospital, Sheffield, United Kingdom
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Discussant: Walter Mingrone, Kantonal Hospital of Olten, Olten, Switzerland
Topics: -

View details

How to avoid overtreatment in node-negative breast cancer: uPA/PAI-1 testing helps to individualize therapy concepts CME accredited

GR58 - 23 July 2009 - 18:15-19:00 CET

Expert: Nadia Harbeck, University Hospital of Cologne, Cologne, Germany
Discussant: Christoph Thomssen, Martin Luther University, Halle/Saale, Germany
Topics: -

View details

Fertility in breast cancer patients CME accredited

GR57 - 16 July 2009 - 18:15-19:00 CET

Expert: Ann H. Partridge, Dana-Farber Cancer Institute, Boston, USA
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milano, Italy
Topics: -

View details

The role of single agent rituximab in the treatment algorithm of follicular lymphoma CME accredited

GR56 - 09 July 2009 - 18:15-19:00 CET

Expert: Michele Ghielmini, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Discussant: Christoph Renner, University Hospital Zurich, Zurich, Switzerland
Topics: -

View details

Cancer on the Internet: Collaboration for Cancer Control CME accredited

GR55 - 02 July 2009 - 18:15-19:00 CET

Expert: Mary Gospodarowicz, Princess Margaret Hospital - University of Toronto, Toronto, Canada
Discussant: Anes Pasic, Institute of Oncology, Sarajevo, Bosnia and Herzegovina
Topics: -

View details

Cardiotoxicity in breast cancer treatment CME accredited

GR54 - 25 June 2009 - 18:15-19:00 CET

Expert: Thomas M. Suter, Cardiology Clinic, University Hospital Berne, Inselspital, Berne, Switzerland
Expert: Evandro de Azambuja, Br.E.A.S.T. Data Centre, Jules Bordet Institute, Brussels, Belgium
Discussant: Mathias Rauchhaus, Center of Internal Medicine University Hospital, Rostock, Germany
Topics: -

View details

From life expectancy to chance of surviving in elderly cancer patients: The concept of frailty CME accredited

GR53 - 18 June 2009 - 18:15-19:00 CET

Expert: Jean-Pierre Droz, Centre Leon-Berard, Lyon, France
Discussant: Catherine Terret, Centre Leon-Berard, Lyon, France
Topics: -

View details

Anal cancer: New thought versus old paradigms CME accredited

GR52 - 11 June 2009 - 18:15-19:00 CET

Expert: Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Northwood, United Kingdom
Discussant: Alec McDonald, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
Topics: -

View details

Angiogenesis as a strategic target for ovarian cancer therapy (based on a Review published in Nature Clinical Practice Oncology) CME accredited

GR51 - 04 June 2009 - 18:15-19:00 CET

Expert: Robert L. Coleman, M.D. Anderson Cancer Center, Houston, USA
Discussant: Brian Slomovitz , Morristown Memorial Hospital , Morristown, USA
Topics: -

View details

Positron emission tomography (PET): What oncologists require from nuclear physicians and vice versa CME accredited

GR50 - 28 May 2009 - 18:15-19:00 CET

Expert: Luca Ceriani, Cantonal Service for Nuclear Medicine, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Discussant: Sergio Suriano, Cantonal Service for Nuclear Medicine, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Topics: -

View details

Selective bladder-preserving therapy with aggressive transurethral surgery and chemoradiation for muscle-invasive bladder cancer (NCPO ViewPoint article) CME accredited

GR48 - 14 May 2009 - 18:15-19:00 CET

Expert: William U. Shipley, Massachusetts General Hospital, Boston, USA
Discussant: Richard Lee, Massachusetts General Hospital, Boston, USA
Topics: -

View details

The ESO Breast Cancer Observatory: A forecast CME accredited

GR47 - 07 May 2009 - 18:15-19:00 CET

Expert: Alberto Costa, Breast Unit of Canton Ticino, Bellinzona, Switzerland
Discussant: Stella Kyriakides, Europa Donna Cyprus, Nicosia, Cyprus
Topics: -

View details

Robotic surgery for prostate cancer CME accredited

GR46 - 30 April 2009 - 18:15-19:00 CET

Expert: Ash Tewari, Weill Cornell Medical College, New York, USA
Discussant: Bernardo Rocco, European Institute of Oncology, Milano, Italy
Topics: -

View details

Neuro-endocrine tumors of the gastro-intestinal tract: Current treatment strategies CME accredited

GR45 - 23 April 2009 - 18:15-19:00 CET

Expert: Lillian Siu, Princess Margaret Hospital, Toronto, Canada
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: -

View details

Retinoblastoma in developing countries. How telemedicine may help (held in co-operation with www.cure4kids.org) CME accredited

GR44 - 16 April 2009 - 18:15-19:00 CET

Expert: Guillermo Chantada, Hospital Garrahan, Buenos Aires, Argentina
Discussant: Francois Doz, Institut Curie, Paris, France
Topics: -

View details

Breast irradiation in patients undergoing breast reconstruction CME accredited

GR43 - 09 April 2009 - 18:15-19:00 CET

Expert: Elzbieta Senkus-Konefka, Medical University of Gdansk, Gdansk, Poland
Discussant: Giuseppe Sasso, Centre Medical Forcilles, Paris, France
Topics: -

View details

Unintended pregnancy during radiotherapy for cancer (NCPO Case Study) CME accredited

GR42 - 02 April 2009 - 18:15-19:00 CET

Expert: Saskia de Wildt, Erasmus Medical Centre Sophia Children's Hospital, Rotterdam, The Netherlands
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milano, Italy
Topics: -

View details

Optimizing approaches to head and neck cancer. Metastatic head and neck cancer - New options CME accredited

GR41 - 26 March 2009 - 18:15-19:00 CET

Expert: Lisa Licitra, National Cancer Institute, Milano, Italy
Discussant: Jan B. Vermorken, University Hospital of Antwerp, Edegem, Belgium
Topics: -

View details

Beyond adjuvant chemotherapy in colorectal cancer: What improves prognosis apart from adjuvant chemotherapy ? CME accredited

GR40 - 19 March 2009 - 18:15-19:00 CET

Expert: Jeffrey Meyerhardt, Dana-Farber Cancer Institute, Boston, USA
Discussant: Daniel Helbling, Onkozentrum Zurich, Zurich, Switzerland
Topics: -

View details

KRAS status and efficacy in the CRYSTAL Study: 1st line treatment of patients with metastatic colorectal cancer receiving Folfiri with or without Cetuximab CME accredited

GR39 - 12 March 2009 - 18:15-19:00 CET

Expert: Eric van Cutsem, University Hospital Gasthuisberg, Leuven, Belgium
Discussant: Fortunato Ciardiello, Second University of Naples, Naples, Italy
Topics: -

View details

Optimal integration of newer agents in the treatment of advanced colorectal cancer CME accredited

GR38 - 05 March 2009 - 18:15-19:00 CET

Expert: Hans-Joachim Schmoll, Martin Luther University, Halle, Germany
Discussant: Dirk Arnold, Martin Luther University, Halle, Germany
Topics: -

View details

Introducing new molecular technologies into routine clinical cancer care: is there an impact on the treatment of breast cancer? CME accredited

GR37 - 26 February 2009 - 18:15-19:00 CET

Expert: Luca Gianni, IRCCS Foundation, National Cancer Institute, Milano, Italy
Discussant: Giampaolo Bianchini, M.D. Anderson Cancer Center, Houston, USA
Topics: -

View details

Advanced epithelial ovarian cancer: Are there improvements in first and second-line treatment? CME accredited

GR36 - 19 February 2009 - 18:15-19:00 CET

Expert: Jan B. Vermorken, University Hospital of Antwerp, Edegem, Belgium
Discussant: Sergio Pecorelli, University of Brescia, Ospedali Civili, Brescia, Italy
Topics: -

View details

Nomograms in prostate cancer: Who, why and when CME accredited

GR35 - 12 February 2009 - 18:15-19:00 CET

Expert: Michael Kattan, Cleveland Clinic, Quantitative Health Sciences, Cleveland, USA
Discussant: Riccardo Valdagni, IRCCS Foundation, National Cancer Institute, Prostate Programme, Milano, Italy
Topics: -

View details

Intensified neoadjuvant chemotherapy in early-relapsing breast cancer: Phase III randomized GeparTrio Study CME accredited

GR34 - 05 February 2009 - 18:15-19:00 CET

Expert: Gunter von Minckwitz, German Breast Cancer Group, Neu-Isenburg, Germany
Discussant: Olivia Pagani, Oncology Institute of Southern Switzerland, Lugano, Switzerland
Topics: -

View details

Open issues in state-of-the-art of adult soft-tissue sarcoma medical therapy CME accredited

GR33 - 29 January 2009 - 18:15-19:00 CET

Expert: Paolo Casali, National Cancer Institute, Milano, Italy
Discussant: Palma Dileo, National Cancer Institute, Milano, Italy
Topics: -

View details

Systemic chemotherapy and new experimental approaches in the treatment of metastatic prostate cancer CME accredited

GR32 - 22 January 2009 - 18:15-19:00 CET

Expert: Cora Sternberg, Ospedale San Camillo Forlanini, Roma, Italy
Discussant: Fabio Calabro', Ospedale San Camillo Forlanini, Roma, Italy
Topics: -

View details

Assessment of the first year of e-grandrounds

GR31 - 15 January 2009 - 18:15-19:15 CET

Expert: Alberto Costa, ESO Director, Milano, Italy
Topics: -

View details

Treatment of Hodgkin's lymphoma today

GR30 - 18 December 2008 - 18:15-19:30 CET

Expert: Volker Diehl, University of Cologne, Cologne, Germany
Expert: Peter Borchmann, University of Cologne, Cologne, Germany
Discussant: Martin F. Fey, University Hospital, Inselspital, Berne, Switzerland
Discussant: Volker Diehl, University of Cologne, Cologne, Germany
Topics: -

View details

Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: Tools or decorations? (Review article published in Nature Clinical Practice Oncology)

GR29 - 11 December 2008 - 18:15-19:00 CET

Expert: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Expert: Curzio Ruegg, University of Lausanne, CEPO Laboratory, Lausanne, Switzerland
Discussant: Emile E. Voest, University Hospital , Utrecht, The Netherlands
Topics: -

View details

How to integrate EGFR targeting in the management of head and neck cancer

GR28 - 04 December 2008 - 18:15-19:00 CET

Expert: Jan B. Vermorken, University Hospital of Antwerp, Edegem, Belgium
Discussant: Pol Specenier, University Hospital Antwerp, Edegem, Belgium
Topics: -

View details

Decision making for systemic treatment in non-small cell lung cancer

GR27 - 27 November 2008 - 18:15-19:00 CET

Expert: Rolf A. Stahel, University Hospital, Zurich, Switzerland
Discussant: Enriqueta Felip, Vall D'Hebron Hospital, Barcelona, Spain
Topics: -

View details

Mechanisms of disease: Angiogenesis and the management of breast cancer (Review article published in Nature Clinical Practice Oncology)

GR26 - 20 November 2008 - 18:15-19:00 CET

Expert: Susana Banerjee, The Breakthrough Breast Cancer Research Centre at The Institute of Cancer Research, London, United Kingdom
Discussant: Lesley-Ann Martin, The Breakthrough Breast Cancer Research Centre at The Institute of Cancer Research, London, United Kingdom
Topics: -

View details

The World Cancer Declaration (held in co-operation with UICC)

GR25 - 13 November 2008 - 18:15-19:00 CET

Expert: Franco Cavalli, UICC Past-President, Bellinzona, Switzerland
Discussant: Kathy Redmond, CancerWorld Editor, Lugano, Switzerland
Topics: -

View details

New oncoplastic techniques avoiding the need for mastectomy (Review article published in Nature Clinical Practice Oncology)

GR24 - 06 November 2008 - 18:15-19:00 CET

Expert: Richard Rainsbury, Royal Hampshire County Hospital, Winchester, United Kingdom
Discussant: Fiona MacNeill, Royal Marsden Hospital, London, United Kingdom
Topics: -

View details

Molecularly-targeted therapy of sarcoma

GR23 - 30 October 2008 - 18:15-19:00 CET

Expert: Jean-Yves Blay, University Claude Bernard, Lyon, France
Discussant: Axel Le Cesne, Institut Gustave Roussy, Villejuif, France
Topics: -

View details

Chronic lymphocitic leukaemia: One or two diseases?

GR22 - 23 October 2008 - 18:15-19:00 CET

Expert: Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Discussant: Martin F. Fey, University Hospital, Inselspital, Berne, Switzerland
Topics: -

View details

Moving to HPV-based cervical cancer screening and prevention programs

GR21 - 16 October 2008 - 18:15-19:00 CET

Expert: Mark Schiffman, National Cancer Institute NIH, Rockville, USA
Discussant: Gary Clifford, IARC, International Agency for Research on Cancer, Lyon, France
Topics: -

View details

Screening for lung cancer with spiral CT is not justified (Viewpoint article published in Nature Clinical Practice Oncology)

GR20 - 09 October 2008 - 18:15-19:00 CET

Expert: Fergus V. Gleeson, Churchill Hospital, Oxford Radcliffe Hospitals, Oxford, United Kingdom
Discussant: Rachel Benamore, Churchill Hospital, Oxford Radcliffe Hospitals, Oxford, United Kingdom
Topics: -

View details

Neoadjuvant chemotherapy for resectable liver metastases. Does the EPOC study establish the standard of care?

GR19 - 25 September 2008 - 18:15-19:00 CET

Expert: Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Northwood, United Kingdom
Discussant: Demetris Papamichael, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
Topics: -

View details

Treating breast cancer in a breast unit

GR18 - 11 September 2008 - 18:15-19:00 CET

Expert: Alberto Costa, Breast Unit of Canton Ticino, Bellinzona, Switzerland
Discussant: Wolfgang Gatzemeier, Humanitas Clinical Institute, Milano, Italy
Topics: -

View details

CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation (Case Study published in Nature Clinical Practice Oncology)

GR17 - 28 August 2008 - 18:15-19:00 CET

Expert: Minggui Pan, Kaiser Permanente Medical Center, Santa Clara, USA
Discussant: Giuseppe Giaccone, CCR National Cancer Institute, Bethesda, USA
Topics: -

View details

The role of adjuvant chemotherapy in endocrine responsive breast cancer

GR16 - 14 August 2008 - 18:15-19:00 CET

Expert: Tanja Cufer, University Clinic Golnik, Golnik, Slovenia
Discussant: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
Topics: -

View details

Hormonal therapy in combination with local treatment of prostate cancer

GR15 - 31 July 2008 - 18:15-19:00 CET

Expert: Elzbieta Senkus-Konefka, Medical University of Gdansk, Gdansk, Poland
Discussant: Hendrik Van Poppel, University Hospital, K.U. Leuven, Leuven, Belgium
Topics: -

View details

Surgery of renal cell carcinoma in 2008

GR14 - 17 July 2008 - 18:15-19:00 CET

Expert: Hendrik Van Poppel, University Hospital, K.U. Leuven, Leuven, Belgium
Discussant: Ziya Kirkali, Dokuz Eylul University, School of Medicine, Izmir, Turkey
Topics: -

View details

Breast cancer in young women (from the ESO Symposium at ECLU)

GR13 - 03 July 2008 - 18:15-19:00 CET

Expert: Stefan Aebi, University Hospital Berne, Inselspital, Berne, Switzerland
Expert: Angela Arnold, Memorial Sloan-Kettering Cancer Center, New York, USA
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milano, Italy
Topics: -

View details

Advanced polypectomy at colonscopy: Pushing the boundaries!

GR12 - 19 June 2008 - 18:15-19:00 CET

Expert: Brian Saunders, St. Mark's Hospital, Wolfson Unit for Endoscopy, Harrow, United Kingdom
Discussant: Lucio Petruzziello, Policlinico A. Gemelli, Roma, Italy
Topics: -

View details

Controversy: Do we need radiotherapy in early Hodgkin's lymphoma? (from the 10th ICML)

GR11 - 05 June 2008 - 18:15-19:00 CET

Expert: Joachim Yahalom, Memorial Sloan-Kettering Cancer Center, New York, USA
Expert: Joseph M. Connors, University of British Columbia Cancer Agency, Vancouver, Canada
Discussant: George P. Canellos, Dana-Farber Cancer Institute, Boston, USA
Topics: -

View details

Controversial issues in the management of locally advanced head and neck cancers

GR10 - 22 May 2008 - 18:15-19:00 CET

Expert: Jacques Bernier, Clinic of Genolier, Genolier, Switzerland
Discussant: Ahmad Awada, Institut Jules Bordet, Brussels, Belgium
Topics: -

View details

Stereotactic radiotherapy for stage I NSCLC: The triumph of technology over biology? (Article published in Nature Clinical Practice Oncology)

GR9 - 08 May 2008 - 18:15-19:00 CET

Expert: Jose S.A. Belderbos, Antoni van Leeuwenhoekhuis, Netherlands Cancer Institute, Amsterdam, The Netherlands
Discussant: Paul Van Houtte, Institut Jules Bordet, Brussels, Belgium
Topics: -

View details

Locally advanced rectal cancer (clinical cases)

GR8 - 24 April 2008 - 18:15-19:00 CET

Expert: Andres Cervantes, Hospital Clinico Universitario, Valencia, Spain
Discussant: Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Northwood, United Kingdom
Topics: -

View details

Patients with a gastrointestinal obstruction due to advanced cancer have to stay in-hospital

GR7 - 10 April 2008 - 18:15-19:00 CET

Expert: Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Antwerp, Belgium
Discussant: Carla Ripamonti, IRCCS Foundation, National Cancer Institute, Milano, Italy
Topics: -

View details

A 61-yr old male pt with AML with +13, no allogeneic donor, CR after induction followed by 2 consolidation courses. Should he undergo an autotransplant?

GR6 - 27 March 2008 - 18:15-19:00 CET

Expert: Luciano Wannesson, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Discussant: Armand Keating, Princess Margaret Hospital, Toronto, Canada
Topics: -

View details

Focal therapy for intermediate-risk prostate cancer: A proposed paradigm shift (Article published in Nature Clinical Practice Oncology)

GR5 - 13 March 2008 - 18:15-19:00 CET

Expert: Hashim Uddin Ahmed, University College London, Institute of Urology, London, United Kingdom
Topics: -

View details

The use of adjuvant chemotherapy in elderly patients with colorectal cancer (clinical cases)

GR4 - 28 February 2008 - 18:15-19:00 CET

Expert: Demetris Papamichael, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
Discussant: Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Northwood, United Kingdom
Topics: -

View details

Excessive and unnecessary surgery in melanoma (Review article in Nature Clinical Practice Oncology)

GR3 - 14 February 2008 - 18:15-19:00 CET

Expert: J. Meirion Thomas, Royal Marsden Hospital, London, United Kingdom
Discussant: Andrew Hayes, Royal Marsden Hospital, London, United Kingdom
Topics: -

View details

Tailored treatment for elderly patients with breast cancer

GR2 - 31 January 2008 - 18:15-19:00 CET

Expert: Riccardo Audisio, Whiston Hospital, University of Liverpool, Prescot, United Kingdom
Discussant: Deborah Boyle, Banner Good Samaritan Medical Center, Phoenix, USA
Topics: -

View details

The concept of metastatic breast cancer guidelines

GR1 - 17 January 2008 - 18:15-19:00 CET

Expert: Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal
Discussant: Alberto Costa, Breast Unit of Canton Ticino, Bellinzona, Switzerland
Topics: -

View details